Effects of the Physical Fitness on Serum Klotho Levels in Healthy Population (CoFiKSa)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03509818 |
Recruitment Status :
Completed
First Posted : April 26, 2018
Last Update Posted : July 23, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy Population | Other: plyometric exercise Other: Aerobic exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 85 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | Description of the sample |
Masking: | Single (Participant) |
Primary Purpose: | Other |
Official Title: | Effects of the Physical Fitness on Serum Klotho Levels in Healthy Population: Response and Adaptation |
Actual Study Start Date : | March 21, 2018 |
Actual Primary Completion Date : | October 30, 2018 |
Actual Study Completion Date : | March 26, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Plyometric
Effects of plyometric acute exercise
|
Other: plyometric exercise
acute plyometric exercise |
Experimental: Aerobic
Effects of aerobic acute exercise
|
Other: Aerobic exercise
acute aerobic exercise |
- Change in serum Klotho levels [ Time Frame: Baseline and one hour ]Change from baseline to acute exercise session
- Change in Cardiorespiratory Fitness VO2max [ Time Frame: Baseline ]For this Variable All people Will perform a exercise test on treadmill (Tecnhogym run race 1400HC; Gambettola, Italy), in this way we determinate the VO2max. Through the modifies Balke protocol. The gas Exchange data Will measured breath by breath using open circuit spirometry and specific face mask for Fitmate, Cosmed; Vmax 29C, Sensormedics machine.
- Change in Body Composition [ Time Frame: Baseline ]The age in years; height in centimeters (tallimeter Ano Sayol SL, Barcelona, Spain); weight in kilograms (Inbody 720, Microcaya) and we can derive from this data the variable of Body Mass Index (BMI) calculated as weight (kg)/height (m2).
- Change in Body Composition, Body muscle mass Index [ Time Frame: Baseline ]For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
- Change in Body Composition, % of Fat Mass [ Time Frame: Baseline ]For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
- Change in Body Composition, Total Muscle Mass [ Time Frame: Baseline ]For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA)
- Change in Body Composition, Visceral Fat Index. [ Time Frame: Baseline ]For determinate this variable of the body composition will be use a Dual Densitometry X-Ray (DXA) (Hologic QDR Discovery, Bedford, MA, USA). This value is really important to determine a cardiovascular risk.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- healthy people between 20 and 45 years old
Exclusion Criteria:
- acute and chronic disease, people who take medication and supplements, smoker.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03509818
Spain | |
Escuela de Doctorado e Invesitgacion, Universidad Europea | |
Madrid, Villaviciosa De Odon, Spain, 28670 |
Principal Investigator: | Valentin Fernandez Elias, Ph | Universidad Europea de Madrid |
Responsible Party: | Margarita Perez, Professor in Exercise Physiology, Universidad Europea de Madrid |
ClinicalTrials.gov Identifier: | NCT03509818 |
Other Study ID Numbers: |
Ref 47/764390.09/17 |
First Posted: | April 26, 2018 Key Record Dates |
Last Update Posted: | July 23, 2019 |
Last Verified: | July 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Klotho Exercise Physical Fitness |